Variant report

Variant	rs886339
Chromosome Location	chr7:27190670-27190671
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr7:27190422-27190751	GM19240	blood:	n/a	n/a
2	CTCF	chr7:27190540-27190690	HVMF	connective:	n/a	n/a
3	MAX	chr7:27190066-27190856	ECC-1	luminal epithelium:	n/a	chr7:27190352-27190361
4	MYBL2	chr7:27190395-27190730	HepG2	liver:	n/a	n/a
5	CTCF	chr7:27190520-27190670	HMF	breast:	n/a	n/a
6	SMARCC1	chr7:27189782-27191078	Hela-S3	cervix:	n/a	n/a
7	SMC3	chr7:27189834-27190826	Hela-S3	cervix:	n/a	n/a
8	CTCF	chr7:27190281-27190757	NHEK	skin:	n/a	n/a
9	CTCF	chr7:27190520-27190670	HEK293	kidney:	n/a	n/a
10	REST	chr7:27190077-27190940	MCF-7	breast:	n/a	chr7:27190847-27190856 chr7:27190353-27190362 chr7:27190348-27190368 chr7:27190349-27190367 chr7:27190354-27190368 chr7:27190348-27190368
11	BHLHE40	chr7:27190451-27190791	K562	blood:	n/a	chr7:27190638-27190654 chr7:27190565-27190581 chr7:27190554-27190570
12	CTCF	chr7:27190580-27190730	GM12878	blood:	n/a	n/a
13	RAD21	chr7:27190465-27190817	Hela-S3	cervix:	n/a	chr7:27190638-27190652 chr7:27190558-27190572 chr7:27190560-27190574
14	REST	chr7:27189942-27191024	A549	lung:	n/a	chr7:27190942-27190955 chr7:27190847-27190856 chr7:27190353-27190362 chr7:27190348-27190368 chr7:27190349-27190367 chr7:27190354-27190368 chr7:27190348-27190368
15	POU2F2	chr7:27190448-27190883	GM12891	blood:	n/a	chr7:27190677-27190684 chr7:27190673-27190688
16	TAF1	chr7:27189918-27190793	A549	lung:	n/a	n/a
17	CTCF	chr7:27190560-27190710	HAc	cerebellar:	n/a	n/a
18	CEBPB	chr7:27190186-27190770	HepG2	liver:	n/a	n/a
19	CTCF	chr7:27190560-27190710	HPAF	blood vessel:	n/a	n/a
20	MAZ	chr7:27190496-27190734	K562	blood:	n/a	n/a
21	CTCF	chr7:27190520-27190670	HCPEpiC	choroid plexus:	n/a	n/a
22	POLR2A	chr7:27189947-27190970	A549	lung:	n/a	n/a
23	CTCF	chr7:27190460-27190712	Hela-S3	cervix:	n/a	n/a
24	CTCF	chr7:27190447-27190743	GM10248	blood:	n/a	n/a
25	MYC	chr7:27190219-27190758	MCF10A-Er-Src	breast:	n/a	chr7:27190352-27190361
26	CTCF	chr7:27190520-27190670	GM12872	blood:	n/a	n/a
27	CTCF	chr7:27190407-27190789	A549	lung:	n/a	n/a
28	ZNF263	chr7:27189861-27191256	HEK293-T-REx	kidney:	n/a	n/a
29	MAX	chr7:27190460-27190710	K562	blood:	n/a	n/a
30	PBX3	chr7:27190295-27191010	SK-N-SH	brain:	n/a	n/a
31	CTCF	chr7:27190520-27190670	GM12874	blood:	n/a	n/a
32	BCL3	chr7:27190403-27191220	A549	lung:	n/a	chr7:27190638-27190651
33	CTCF	chr7:27190520-27190670	BJ	skin:	n/a	n/a
34	PBX3	chr7:27190340-27190898	SK-N-SH	brain:	n/a	n/a
35	JUND	chr7:27190453-27190745	H1-hESC	embryonic stem cell:	n/a	n/a
36	YY1	chr7:27189958-27190759	HepG2	liver:	n/a	chr7:27190570-27190584 chr7:27190641-27190652 chr7:27190638-27190652
37	MAZ	chr7:27190209-27190965	GM12878	blood:	n/a	chr7:27190352-27190361
38	MAX	chr7:27189704-27190915	A549	lung:	n/a	chr7:27190352-27190361
39	MAX	chr7:27189901-27190791	Hela-S3	cervix:	n/a	chr7:27190352-27190361
40	CTCF	chr7:27190560-27190710	GM06990	blood:	n/a	n/a
41	E2F4	chr7:27190427-27190701	MCF10A-Er-Src	breast:	n/a	chr7:27190567-27190577
42	SIN3AK20	chr7:27190426-27190787	SK-N-SH	brain:	n/a	n/a
43	TCF12	chr7:27190453-27190676	GM12878	blood:	n/a	chr7:27190565-27190572
44	CTCF	chr7:27190233-27190758	MCF-7	breast:	n/a	n/a
45	CTBP2	chr7:27190256-27192020	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr7:27190445-27190696	T-47D	breast:	n/a	n/a
47	MAX	chr7:27190075-27191084	NB4	blood:	n/a	chr7:27190352-27190361
48	RAD21	chr7:27190423-27190757	HepG2	liver:	n/a	chr7:27190638-27190652 chr7:27190558-27190572 chr7:27190560-27190574
49	CTCF	chr7:27190520-27190670	Hela-S3	cervix:	n/a	n/a
50	POLR2A	chr7:27189921-27191037	A549	lung:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:27190581..27191427-chr7:27198722..27199664,2	K562	blood:
2	chr7:27190534..27191089-chr7:27200653..27201204,2	K562	blood:
3	7:27082525-27089724..7:27181770-27195105	Hela-S3	cervix:
4	7:27181770-27195105..7:27230275-27238414	GM12878	blood:
5	chr7:26883032..26883964-chr7:27190330..27191296,3	MCF-7	breast:
6	7:27162022-27164727..7:27181770-27195105	H1-hESC	embryonic stem cell:	embryo
7	chr7:27181480..27183219-chr7:27189259..27191878,2	MCF-7	breast:
8	chr7:25620314..25621226-chr7:27190549..27191075,2	Hela-S3	cervix:
9	chr7:27184989..27187193-chr7:27189201..27192004,2	MCF-7	breast:
10	chr7:27181736..27184705-chr7:27188724..27191664,4	MCF-7	breast:
11	chr7:27169441..27172151-chr7:27190133..27191991,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-EVX1-8	chr7:27189671-27191300	ENSG00000254369

Variant related genes	Relation type
HOXA6	TF binding region
ENSG00000106031	Chromatin interaction
ENSG00000254369	Chromatin interaction
ENSG00000213786	Chromatin interaction
ENSG00000253508	Chromatin interaction
ENSG00000253552	Chromatin interaction
ENSG00000197576	Chromatin interaction
ENSG00000106004	Chromatin interaction
ENSG00000243766	Chromatin interaction

Extended variants
information (count: 93 )
Associated
traits (count: 3 )

rSNPs within LD-proxies of this variant (count:55)

rs_ID	r²[population]
rs10085570	1.00[CEU][hapmap];0.90[JPT][hapmap];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs10225507	0.81[ASN][1000 genomes]
rs10238095	1.00[ASN][1000 genomes]
rs10246712	0.91[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs11564055	0.90[JPT][hapmap];0.89[ASN][1000 genomes]
rs11762730	0.91[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs11983200	0.91[JPT][hapmap];0.86[YRI][hapmap];0.96[AFR][1000 genomes];0.91[AMR][1000 genomes];0.85[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs12530948	1.00[ASN][1000 genomes]
rs12533947	0.90[JPT][hapmap];0.91[ASN][1000 genomes]
rs12666919	1.00[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];0.80[YRI][hapmap];0.96[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12666926	1.00[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];0.96[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs1548497	0.90[JPT][hapmap];0.83[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs1725074	0.81[CHB][hapmap];0.86[JPT][hapmap];0.87[ASN][1000 genomes]
rs17449108	0.90[JPT][hapmap];0.91[ASN][1000 genomes]
rs17471485	0.90[JPT][hapmap];0.91[ASN][1000 genomes]
rs17471520	0.90[JPT][hapmap];0.94[ASN][1000 genomes]
rs1801085	0.90[JPT][hapmap];0.93[ASN][1000 genomes]
rs1859166	0.90[JPT][hapmap];0.93[ASN][1000 genomes]
rs2107063	1.00[CEU][hapmap];0.90[JPT][hapmap];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2285722	0.90[ASN][1000 genomes]
rs2301720	0.91[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2301721	0.82[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes]
rs2428432	0.90[JPT][hapmap];0.89[ASN][1000 genomes]
rs2428433	0.90[JPT][hapmap];0.89[ASN][1000 genomes]
rs2428434	0.90[JPT][hapmap];0.90[ASN][1000 genomes]
rs2465275	0.90[JPT][hapmap];0.89[ASN][1000 genomes]
rs2465276	0.90[JPT][hapmap];0.90[ASN][1000 genomes]
rs3735530	0.83[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes]
rs3801320	0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs3807597	1.00[CEU][hapmap];1.00[JPT][hapmap]
rs3823764	0.83[CEU][hapmap];0.83[CHB][hapmap];1.00[JPT][hapmap];0.93[ASN][1000 genomes]
rs4722657	1.00[CEU][hapmap];0.90[JPT][hapmap];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs4722659	1.00[CEU][hapmap];0.90[JPT][hapmap];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs4722666	0.96[ASN][1000 genomes]
rs61384251	0.90[ASN][1000 genomes]
rs6461985	0.90[JPT][hapmap];0.93[ASN][1000 genomes]
rs6461987	0.90[JPT][hapmap];0.80[AFR][1000 genomes];0.85[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs68021164	0.97[ASN][1000 genomes]
rs6948297	0.90[JPT][hapmap];0.80[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs6957209	0.90[JPT][hapmap];0.83[AFR][1000 genomes];0.83[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs6962314	0.82[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs6969780	0.90[JPT][hapmap];0.93[ASN][1000 genomes]
rs6973182	0.90[JPT][hapmap];0.83[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs6976129	0.83[CHB][hapmap];0.90[JPT][hapmap];0.83[AFR][1000 genomes];0.86[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs73071548	0.82[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs73071550	0.93[ASN][1000 genomes]
rs7341470	1.00[CEU][hapmap];1.00[JPT][hapmap];0.83[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs739734	0.90[JPT][hapmap];0.82[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs7798733	0.93[ASN][1000 genomes]
rs7811753	0.91[CEU][hapmap];0.90[JPT][hapmap]
rs875898	0.83[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes]
rs929249	0.90[JPT][hapmap];0.82[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs983184	0.83[CEU][hapmap];1.00[ASN][1000 genomes]
rs983185	1.00[ASN][1000 genomes]
rs985652	0.83[CEU][hapmap];1.00[JPT][hapmap];0.99[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:38 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1025538	chr7:26482342-27376045	Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
2	nsv538805	chr7:26482342-27376045	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
3	nsv1018709	chr7:26990384-27216552	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	140 gene(s)	inside rSNPs	diseases
4	nsv538806	chr7:26990384-27216552	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Genic enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	140 gene(s)	inside rSNPs	diseases
5	nsv887856	chr7:27073731-27297791	Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
6	nsv824038	chr7:27119294-27284522	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
7	nsv887857	chr7:27120689-27229549	Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	176 gene(s)	inside rSNPs	diseases
8	nsv824039	chr7:27121825-27294951	Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
9	nsv824040	chr7:27121870-27295010	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
10	nsv887860	chr7:27127231-27196069	Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
11	nsv887859	chr7:27127231-27196113	Bivalent Enhancer Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
12	nsv887861	chr7:27127231-27206688	Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	75 gene(s)	inside rSNPs	diseases
13	nsv887862	chr7:27127231-27217359	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	141 gene(s)	inside rSNPs	diseases
14	nsv887863	chr7:27127231-27243106	Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
15	nsv887864	chr7:27127231-27243962	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
16	nsv887865	chr7:27127231-27247279	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
17	nsv887866	chr7:27127231-27248373	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
18	nsv887867	chr7:27127231-27252246	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
19	nsv824041	chr7:27128039-27294951	Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
20	nsv887868	chr7:27135314-27202289	Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
21	nsv887869	chr7:27135314-27297791	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
22	nsv887874	chr7:27136308-27196069	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
23	nsv1020608	chr7:27139892-27324004	Bivalent Enhancer Active TSS Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
24	nsv538807	chr7:27139892-27324004	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
25	nsv1033316	chr7:27140645-27237951	Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	178 gene(s)	inside rSNPs	diseases
26	nsv606465	chr7:27143757-27229549	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	174 gene(s)	inside rSNPs	diseases
27	nsv606466	chr7:27145024-27197319	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
28	nsv606467	chr7:27145100-27196113	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
29	nsv887875	chr7:27145100-27243962	Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	179 gene(s)	inside rSNPs	diseases
30	nsv532118	chr7:27146920-27354205	Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
31	nsv5674	chr7:27152562-27197341	Bivalent Enhancer Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases
32	nsv887876	chr7:27168858-27196069	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
33	nsv824042	chr7:27169231-27247232	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
34	nsv887877	chr7:27169388-27217359	Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	115 gene(s)	inside rSNPs	diseases
35	nsv887878	chr7:27175295-27214557	Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	105 gene(s)	inside rSNPs	diseases
36	nsv887879	chr7:27175295-27297791	Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Active TSS Flanking Bivalent TSS/Enh Genic enhancers Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	151 gene(s)	inside rSNPs	diseases
37	esv1798853	chr7:27181568-27309266	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	150 gene(s)	inside rSNPs	diseases
38	nsv526526	chr7:27182142-27196113	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases

mRNA abundance (count:3)

SNP	Gene	Cis/trans	Tissue	Source
rs886339	HOTAIRM1	cis	Esophagus Muscularis	GTEx
rs886339	HOTAIRM1	cis	lung	GTEx
rs886339	HOXA2	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:121 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:27186600-27191600	Flanking Active TSS	Adipose Nuclei	Adipose
2	chr7:27186600-27193000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
3	chr7:27186800-27202600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr7:27187200-27192400	Active TSS	Psoas Muscle	Psoas
5	chr7:27187400-27190800	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
6	chr7:27188400-27192400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr7:27188400-27192800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr7:27188800-27192600	Active TSS	NHLF	lung
9	chr7:27189000-27192600	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr7:27189200-27190800	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr7:27189200-27192600	Active TSS	NHDF-Ad	bronchial
12	chr7:27189400-27190800	Active TSS	Fetal Kidney	kidney
13	chr7:27189400-27190800	Active TSS	Dnd41	blood
14	chr7:27189400-27190800	Active TSS	NHEK	skin
15	chr7:27189400-27191200	Active TSS	A549	lung
16	chr7:27189800-27190800	Flanking Active TSS	Colonic Mucosa	Colon
17	chr7:27189800-27190800	Active TSS	Esophagus	oesophagus
18	chr7:27189800-27190800	Active TSS	Small Intestine	intestine
19	chr7:27189800-27191200	Flanking Bivalent TSS/Enh	Primary Natural Killer cells fromperipheralblood	blood
20	chr7:27189800-27191200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr7:27189800-27191600	Active TSS	Sigmoid Colon	Sigmoid Colon
22	chr7:27189800-27192000	Enhancers	Spleen	Spleen
23	chr7:27189800-27192200	Active TSS	Aorta	Aorta
24	chr7:27189800-27192200	Flanking Active TSS	HMEC	breast
25	chr7:27189800-27192400	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
26	chr7:27189800-27192600	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr7:27189800-27192600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
28	chr7:27190000-27190800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr7:27190000-27190800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
30	chr7:27190000-27190800	Bivalent Enhancer	Stomach Mucosa	stomach
31	chr7:27190000-27190800	Bivalent/Poised TSS	HepG2	liver
32	chr7:27190000-27191200	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
33	chr7:27190000-27191200	Flanking Bivalent TSS/Enh	Thymus	Thymus
34	chr7:27190000-27191400	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
35	chr7:27190000-27191400	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
36	chr7:27190000-27191400	Flanking Bivalent TSS/Enh	Fetal Intestine Large	intestine
37	chr7:27190000-27191400	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
38	chr7:27190000-27192400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
39	chr7:27190000-27192800	Active TSS	Colon Smooth Muscle	Colon
40	chr7:27190200-27190800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
41	chr7:27190200-27190800	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr7:27190200-27190800	Active TSS	Primary hematopoietic stem cells	blood
43	chr7:27190200-27190800	Bivalent/Poised TSS	GM12878-XiMat	blood
44	chr7:27190200-27191000	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr7:27190200-27191000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
46	chr7:27190200-27191000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr7:27190200-27191000	Flanking Bivalent TSS/Enh	Primary monocytes fromperipheralblood	blood
48	chr7:27190200-27191000	Bivalent Enhancer	Primary B cells from cord blood	blood
49	chr7:27190200-27191000	Bivalent/Poised TSS	Primary mononuclear cells fromperipheralblood	Blood
50	chr7:27190200-27191000	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links